Autonomix Medical (AMIX) Cash & Equivalents (2022 - 2025)

Autonomix Medical (AMIX) has 4 years of Cash & Equivalents data on file, last reported at $7.5 million in Q3 2025.

• Cash & Equivalents for Q3 2025 came in at $7.5 million, up 43.79% year-over-year; the trailing twelve-month figure through Sep 2025 was $7.5 million (up 43.79% YoY), and the FY2024 annual result was $8.6 million, changed N/A from the prior year.
• Cash & Equivalents declined to $7.5 million in Q3 2025 per AMIX's latest filing, from $8.6 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $11.8 million in Q4 2024 and troughed at $810000.0 in Q4 2022.
• A 4-year average of $6.3 million and a median of $7.1 million in 2024 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2024 and 2025: Cash & Equivalents surged 870.69% in 2024, then increased 26.47% in 2025.
• A 4-year view of Cash & Equivalents shows it stood at $810000.0 in 2022, then soared by 50.37% to $1.2 million in 2023, then surged by 870.69% to $11.8 million in 2024, then tumbled by 36.76% to $7.5 million in 2025.
• Business Quant data shows AMIX's Cash & Equivalents at $7.5 million in Q3 2025, $8.6 million in Q2 2025, and $11.8 million in Q4 2024.